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Ambulatory Blood Pressure and 10-Year Risk of
Cardiovascular and Noncardiovascular Mortality
The Ohasama Study
Masahiro Kikuya, Takayoshi Ohkubo, Kei Asayama, Hirohito Metoki, Taku Obara, Shin Saito,
Junichiro Hashimoto, Kazuhito Totsune, Haruhisa Hoshi, Hiroshi Satoh, Yutaka Imai
Abstract—The objective of this study was to elucidate the long-term prognostic significance of ambulatory blood pressure.
Ambulatory and casual blood pressure values were obtained from 1332 subjects (872 women and 460 men) aged 40
years from the general population of a rural Japanese community. Survival was then followed for 14 370 patient years
and analyzed by a Cox hazard model adjusted for possible confounding factors. There were 72 cardiovascular deaths
during the 10.8-year follow-up. The relationship between 24-hour systolic blood pressure and the cardiovascular
mortality risk was U-shaped in the first 5 years, then changed to J-shaped over the rest of the 10.8-year follow-up. After
censoring the first 2 years of data, the risk flattened until it again increased for the fifth quintile of 24-hour systolic blood
pressure for the 10.8-year follow-up period. For 24-hour diastolic blood pressure, the J-shaped relationship remained
unchanged, regardless of follow-up duration and censoring. Ambulatory systolic blood pressure values consistently
showed stronger predictive power for cardiovascular mortality risk than did casual systolic blood pressure in the
10.8-year follow-up data, whereas such relationships became more marked after censoring the first 2 years. When
nighttime and daytime systolic blood pressure values were simultaneously included in the same Cox model, only
nighttime blood pressure significantly predicted the cardiovascular mortality risk for the 10.8-year follow-up data. We
conclude that the relationship between ambulatory systolic blood pressure and cardiovascular mortality is not U-shaped
or J-shaped, and that nighttime blood pressure has better prognostic value than daytime blood pressure. (Hypertension.
2005;45:240-245.)
Key Words: blood pressure monitoring, ambulatory  cardiovascular diseases  prospective studies
Ambulatory blood pressure (BP) has been used widely todiagnose and evaluate hypertension and to monitor
treatment in the clinical setting.1,2 Moreover, ambulatory BP
is known to provide more reproducible information than does
casual BP for individual patients with hypertension, 3,4 and is
more strongly correlated with target-organ damage than
casual BP in hypertensive subjects. Furthermore, the interna-
tional guidelines for hypertension have emphasized the use-
fulness of ambulatory BP.5,6 However, in contrast to the
plethora of evidence about casual BP, there is still a lack of
data that address the long-term prognostic significance of
ambulatory BP. Few longitudinal studies, after 10 years,
have so far examined the relationship between 24-hour BP
and prognosis. Since 1987, we have been conducting a
prospective cohort study to investigate the relationship be-
tween ambulatory BP and survival in the general population
of Ohasama, Japan (the Ohasama Study).7–9 In a previous
report, we presented the results from a 5.1-year follow-up
period.8 The objective of the present study was to determine
the prognostic significance of ambulatory BP for cardiovas-
cular mortality risk based on a longer follow-up period, of the
same subjects, of 10 years.
Methods
Design
The background rationale, study population, and BP measurement of
the Ohasama Study have been presented in detail previously.7–9 The
study protocol was approved by the institutional review board of
Tohoku University School of Medicine and by the Department of
Health of the Ohasama Town Government, and all participants gave
written informed consent.
Study Population
Ambulatory BP data were obtained from 1542 subjects aged 40
years from the general population of a rural Japanese community.8
The 1542 subjects were confirmed previously to be representative of
the general Japanese population.8 Of the 1542 subjects, the 1332
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(86%) who underwent casual BP measurement were the final study
population.8
Ambulatory BP Monitoring and Casual
BP Measurement
Ambulatory BP was monitored every 30 minutes oscillometrically
using an automatic device (ABPM-630; Nippon Colin) and was
edited according to criteria described previously.10 Next, 24-hour
daytime (waking periods) and nighttime (sleeping periods) BP was
calculated for each subject.8 Casual BP was the mean of 2 consec-
utive readings measured by nurses or technicians with subjects in a
seated position after resting for 2 minutes, using a fully automatic
device (USM-700F; UEDA Electronic Works Co.), based on the
Korotkoff sound technique. Both devices for ambulatory and casual
BP have been validated previously11,12 and meet the criteria of the
Association for the Advancement of Medical Instrumentation.13
Follow-Up and Outcomes
Primary and secondary outcomes were determined as mortality from
cardiovascular disease and noncardiovascular disease, respectively
(censor date September 30, 2002). We reviewed death certificates
from the national mortality registry and confirmed the results by
checking the medical records of Ohasama Hospital, which is the only
hospital in the town, and where 90% of subjects undergo regular
check-ups. Most cases were admitted to Ohasama Hospital, where
stroke was diagnosed by computed tomography or MRI of the brain.
According to recommendations of the 10th Revision of the Interna-
tional Classification of Diseases (ICD-10) of the World Health
Organization, cardiovascular death was defined as mortality related
to disease of the circulatory system (ICD-10 code I). Stroke, heart
disease, cancer, and respiratory diseases were ICD code I6, I other
than I6, C00-D48, and J, respectively.
Data Analysis
Association between the BP values and mortality was examined
using the Cox proportional hazards regression model adjusted for
age, gender, smoking status, use of antihypertensive medication at
baseline, and history of cardiovascular disease, diabetes, and
hypercholesterolemia.9
We used 4 durations of follow-up: the first analyses involved the
first 5 years of follow-up from the baseline; the second involved 10.8
years of follow-up; the third involved 10.8 years of follow-up but
excluded death within the first 2 years; and the fourth involved 10.8
years of follow-up but excluded death within the first 4 years. The
rationale for exclusion of the first 2 years of follow-up was based on
a previous study on casual BP,14 which determined that removal of
such data adjusted the reverse-causality bias supposedly derived
from the poor health conditions of subjects with lower BP.14–17
Data represent meanSD. Differences at P0.05 were considered
statistically significant. All statistical analyses were conducted using
SAS version 8.2 software (SAS Institute).
Results
Clinical Characteristics at Baseline
The mean age of the 1332 participants was 61.89.9 years.
Of those, 460 (34.5%) were male, 416 (31.2%) were over-
weight (body mass index 25 kg/m2), 405 (30.4%) were
taking antihypertensive medication, 272 (20.4%) were cur-
rent or past smokers, 217 (16.3%) had hypercholesterolemia,
232 (17.4%) had diabetes mellitus, and 75 (5.6%) experi-
enced previous cardiovascular disease. The mean duration of
ambulatory BP monitoring was 22.32.3 hours. The 24-hour
daytime and nighttime BP values were 123.313.0/
72.07.7, 128.913.9/76.18.4, and 112.314.4/
64.18.1 mm Hg, respectively, and were significantly lower
than the casual systolic and diastolic BP values (131.218.5
and74.111.3 mm Hg, respectively; both P0.001).
Follow-Up and Outcomes
The mean duration of follow-up was 10.82.9 (maximum
14.3) years. Of the 1332 study subjects, 26 (2.0%) moved
away or were lost to follow-up. The total number of patient
years was 14 370. Cardiovascular and noncardiovascular
death occurred in 72 and 142 subjects (5.0 and 9.9 deaths per
1000 person years), respectively. Among the 72 cardiovas-
cular deaths, 37 were from stroke, and 35 were from heart
disease. Among the 142 noncardiovascular deaths, the most
common cause was cancer (61 deaths), followed by diseases
of the respiratory system (26 deaths).
Of the 72 cardiovascular deaths, the 10 who died in the first
2 years of follow-up tended to have lower baseline 24-hour
and casual systolic BP values than the remaining cardiovas-
cular victims; the differences and 95% confidence interval
(CI) were on average 9.3 mm Hg (0.1818.8; P0.05) for
24-hour systolic BP and 10.3 mm Hg (2.2822.9; P0.10)
for casual systolic BP. The differences and 95% CI between
cardiovascular disease victims in the first 4 years (n18) and
the remaining cardiovascular disease victims were
4.7 mm Hg (2.9812.4; P0.23) for 24-hour systolic BP
and 6.7 mm Hg (3.4216.8; P0.23) for casual systolic
BP. Among the 142 noncardiovascular disease victims, there
were rather small differences in mean ambulatory and casual
systolic BP between those who died in the first 2 years
(n10) and the remaining noncardiovascular disease victims.
The differences were on average2.2 mm Hg (11.36.92;
P0.60) for 24-hour systolic BP and 0.6 mm Hg
(13.114.3; P0.93) for casual systolic BP. For diastolic
24-hour and casual BP, the differences in BP values between
subjects who died in the first 2 years of follow-up and the
remaining victims were not statistically significant, regardless
of cardiovascular or noncardiovascular death (all P0.2).
Cardiovascular Mortality
(Nonparametric Analyses)
In the first 5 years of follow-up, a so-called U-shaped
relationship was observed between 24-hour ambulatory sys-
tolic BP and the risk of the cardiovascular mortality (Figure
1a). When the follow-up period was extended to 10.8 years
(up to 14.3 years), the relationship between 24-hour systolic
BP and risk changed from a U-shaped to a J-shaped relation-
ship (Figure 1b). The highest quintiles of 24-hour ambulatory
systolic and diastolic BP and casual systolic BP were asso-
ciated with a significantly increased risk of cardiovascular
mortality. After censoring deaths in the first 2 years, the risks
for the highest quintiles became more prominent, and the
risks for lower quintiles of systolic 24-hour BP were reduced
(Figure 1c). Censoring of death in the first 4 years did not
change the results (data not shown). The other BP values,
except for casual diastolic BP, showed similar results (Figure
1b and 1c).
Cardiovascular Mortality (Parametric Analyses)
In the first 5 years of follow-up, only nighttime BP values
were associated with cardiovascular mortality risk (Table). In
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the 10.8 years of follow-up, the risk of cardiovascular
mortality significantly increased, with an increase in BP
values other than casual systolic, casual diastolic, 24-hour
diastolic, and daytime diastolic BP (Table). After censoring
of death in the first 2 years, the relative hazards (RHs) of
cardiovascular mortality with all BP values tended to be
higher; however, casual, 24-hour, and daytime diastolic BP
were not significantly associated with cardiovascular mortal-
ity (Table). The effect of censoring the first 4 years of data on
the elevation of RH was similar to that of the 2 years of
censoring (Table). No significant interaction was observed
between antihypertensive treatment and BP values on the risk
of cardiovascular mortality in the first 10.8 years of follow-up
(all P0.05).
When 24-hour and casual systolic values were simulta-
neously included into a Cox model of the 10.8 years of
follow-up, only 24-hour systolic BP was significantly related
to the cardiovascular mortality risk: the RHs (95% CI) with
10-mm Hg increments in BP values were 1.28 (1.051.55)
for 24-hour systolic and 1.06 (0.931.21) for casual systolic.
Furthermore, after removal of 24-hour systolic BP from the
model, 2log likelihood (ie, “goodness of model fit”) was
significantly impaired (P0.02), whereas removal of casual
systolic BP from the model did not change the goodness of
Figure 1. RHs and 95% CIs (in paren-
theses) for cardiovascular mortality
adjusted for gender, age, antihyperten-
sive medication, smoking habit, hyper-
cholesterolemia, diabetes mellitus, and
past history of cardiovascular disease
during 5-year follow-up (a), 10.8-year
follow-up (b), and 10.8-year follow-up (c)
after censoring of death in the first 2
years. *P0.05.
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model fit (P0.4). These results were more obvious after
censoring of the first 2 or 4 years: all P0.005 when
ambulatory BP was removed; all P0.2 when casual BP was
removed. In addition, these results were almost identical for
the other ambulatory BP values other than 24-hour or daytime
diastolic BP values, which were not associated with cardio-
vascular mortality after adjusting casual BP.
When daytime and nighttime systolic ambulatory BP
values were simultaneously included into a Cox model of
10.8 years follow-up, only nighttime systolic BP was signif-
icantly related to the cardiovascular mortality risk: the RHs
(95% CI) with 10-mm Hg increments in BP values were 1.32
(1.061.64) for nighttime systolic and 1.03 (0.831.29) for
daytime systolic BP. Furthermore, removal of nighttime
systolic BP from the model of 10.8 years of follow-up
significantly impaired the goodness of model fit (P0.02),
whereas removal of daytime systolic BP from the model did
not change the goodness of model fit (P0.8). After censor-
ing of the first 2 or 4 years, these results were more obvious:
all P0.01 when nighttime systolic BP was removed; all
P0.5 when daytime systolic BP was removed. For diastolic
BP values, these results were similar but not significant.
Noncardiovascular Mortality
In the nonparametric analyses, the lowest quintile of 24-hour and
daytime diastolic BP values was associated with a significantly
increased risk of noncardiovascular mortality, regardless of
follow-up period or censoring of death (Figure 2). This tendency
did not change after censoring of the first 4 or 6 years (data not
shown). The other BP values showed inconsistent or no associ-
ation with noncardiovascular mortality. In the parametric anal-
yses, decreases in BP values tended to be related to noncardio-
vascular death risks but not statistically significantly (Table).
Death by cancer, which was the leading cause of noncardiovas-
cular death, was also significantly related to lower levels of
24-hour ambulatory BP (RH, 0.76; 95% CI, 0.630.92;
P0.005 for each 5 mm Hg) and casual diastolic BP (RH, 0.86;
95% CI, 0.760.96; P0.008 for each 5 mm Hg) in the
10.8-year follow-up. After censoring of the first 2 or 4 years, the
significant relationship was maintained (all P0.02). The other
BP values, except for ambulatory and casual systolic BP,
produced almost identical results (data not shown).
Discussion
Several meta-analyses of prospective observational cohort
studies18–19 and randomized clinical trials20 based on casual
RHs (95% CIs) for BP Values as a Continuous Variable
Duration of Follow-Up
5-Year
Follow-Up
10.8-Year
Follow-Up
10.8-Year Follow-Up
(First 2 Years Censored)
10.8-Year Follow-Up
(First 4 Years Censored)
Cardiovascular death
Death, No. 23 72 62 54
Systolic BP
24-hour 1.31 (0.96–1.77) 1.32 (1.10–1.58)† 1.45 (1.19–1.75)‡ 1.46 (1.18–1.80)‡
Daytime 1.20 (0.91–1.59) 1.23 (1.05–1.46)* 1.33 (1.12–1.59)† 1.34 (1.10–1.62)†
Nighttime 1.39 (1.05–1.85)* 1.34 (1.14–1.59)‡ 1.45 (1.21–1.73)‡ 1.48 (1.22–1.80)‡
Casual 1.08 (0.87–1.34) 1.12 (0.99–1.27) 1.18 (1.04–1.34)* 1.19 (1.04–1.36)*
Diastolic BP
24-hour 1.22 (0.94–1.60) 1.13 (0.97–1.33) 1.20 (1.01–1.41)* 1.18 (0.98–1.42)
Daytime 1.14 (0.89–1.45) 1.10 (0.95–1.26) 1.15 (0.99–1.34) 1.13 (0.96–1.34)
Nighttime 1.31 (1.02–1.68)* 1.19 (1.02–1.38)* 1.24 (1.05–1.46)* 1.24 (1.04–1.48)*
Casual 1.16 (0.97–1.39) 1.02 (0.92–1.13) 1.02 (0.92–1.14) 1.00 (0.89–1.12)
Noncardiovascular death
Death, No. 35 142 132 113
Systolic BP
24-hour 0.94 (0.72–1.22) 0.95 (0.83–1.09) 0.94 (0.82–1.08) 0.91 (0.78–1.07)
Daytime 0.89 (0.70–1.15) 0.95 (0.84–1.08) 0.95 (0.84–1.08) 0.94 (0.81–1.08)
Nighttime 1.08 (0.86–1.37) 1.00 (0.88–1.13) 0.98 (0.86–1.11) 0.94 (0.82–1.09)
Casual 1.02 (0.85–1.23) 0.98 (0.90–1.08) 0.98 (0.89–1.08) 0.97 (0.87–1.07)
Diastolic BP
24-hour 0.83 (0.65–1.06) 0.90 (0.80–1.01) 0.90 (0.79–1.01) 0.88 (0.77–1.01)
Daytime 0.84 (0.67–1.04) 0.92 (0.83–1.02) 0.93 (0.83–1.03) 0.91 (0.81–1.03)
Nighttime 0.94 (0.75–1.17) 0.93 (0.83–1.04) 0.92 (0.82–1.03) 0.90 (0.79–1.03)
Casual 0.98 (0.84–1.14) 0.97 (0.91–1.05) 0.98 (0.91–1.06) 0.97 (0.90–1.06)
RH (95% CIs) indicated the risk associated with a 10-mm Hg and 5-mm Hg increase in systolic and diastolic BP, respectively. RHs
were adjusted for sex, age, antihypertensive medication, smoking status, hypercholesterolemia, diabetes mellitus, and past history
of cardiovascular disease.
*P0.05; †P0.01; ‡P0.001.
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BP have concluded that the relationship between casual BP
and cardiovascular mortality is essentially linear. Ambulatory
BP has also been suggested to have a positively linear or
curvilinear relationship with cardiovascular mortality and
morbidity.21–24 This may be partially supported by the obser-
vation noted in the present study that the increased risk for
cardiovascular mortality at lower BP was reduced after
censoring of death in the first several years to adjust the
reverse-causality bias supposedly derived from the poor
health conditions of subjects with lower BP.14–17
In the present study, cardiovascular victims in the first 2
years of follow-up tended to have lower baseline systolic BP
values than the remaining cardiovascular victims. However,
the magnitude of the BP difference between the cardiovas-
cular victims in the first 4 years of follow-up and those after
the 4 years was lower. Furthermore, the effect of the 2-year
censoring on the RH of cardiovascular mortality was similar
to that of the 4-year censoring (Table). These results suggest
that 2-year censoring is an appropriate period with which to
exclude reverse-causality bias effectively without losing sta-
tistical power.
After adjustment of the reverse-causality by censoring of
the first several years of follow-up, we found a stronger RH
of cardiovascular mortality with ambulatory BP compared
with those of previous studies in which censoring was not
conducted.21–23 For example, the RH (95% CI) of cardiovas-
cular mortality with a 10 mm Hg increase in the 24-hour
systolic BP before censoring of the first several years was
only 1.32 (1.101.58), which is very similar to that observed
in the Syst-Eur Trial,21 in which censoring of the first several
years was not conducted (RH, 1.34 [1.031.75]). In the
present study, censoring of death in the first 2 years produced
an enhanced RH of 1.45 (1.191.75).
There is a growing body of evidence,21–24 including our
previous reports,8,9,25 that ambulatory BP provides better
prognostic value than casual BP, although the median
follow-up of all these reports was 10 years. In the present
study, we validated the previous findings using data from
long-term follow-up (ie, 10 years). We also found that
censoring of the first several years made the superiority of
ambulatory BP to casual BP more marked.
Although daytime BP has been reported to be a good
predictor of outcomes,8,21–25 some studies have shown night-
time BP to be a stronger predictor of cardiovascular mortal-
ity.21,26 The Syst-Eur Trial21 found that only nighttime BP
was a significant predictor of cardiovascular mortality the
among placebo and total groups when daytime and nighttime
BP were included in the same Cox model. This previous
finding was confirmed with the longer follow-up period and
censoring of the first several years in the present study.
For noncardiovascular mortality, we observed an increased
risk in lower BP values regardless of follow-up period and
censoring. A deterioration in general health is a possible
mechanism.17 Another possibility is that low BP is mediated
by less activity. In fact, in the present study, the association
between low BP and noncardiovascular mortality was ob-
served only for 24-hour and daytime ambulatory diastolic BP
values, which were measured under unrestricted physical
activity, and was not observed for casual and nighttime
ambulatory BP values, which were measured under fixed
conditions and during sleep, respectively. In the present
study, we also observed an inverse association between
cancer death risk and diastolic BP values, regardless of
censoring of the first several years, supporting a previous
study27 but not all.28,29 Further studies are required to clarify
this controversy.
Perspectives
We conclude that in the general Japanese population, ambu-
latory systolic BP predicts cardiovascular mortality risk after
correcting for reverse-causality bias. In addition, nighttime
BP is a stronger predictor of cardiovascular mortality than
Figure 2. RHs and 95% CIs (in paren-
theses) for noncardiovascular mortality
adjusted for gender, age, antihyperten-
sive medication, smoking, hypercholes-
terolemia, diabetes mellitus, and past
history of cardiovascular disease during
10.8-year follow-up (a), and 10.8-year
follow-up (b) after censoring of death in
the first 2 years. *P0.05.
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daytime BP. The present study further demonstrated the
better prognostic value of ambulatory BP than casual BP,
using long-term follow-up data from 10 years and censor-
ing of the first several years.
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